Pharmacokinetics in sheep and cattle of albendazole administered by an intraruminal slow release capsule.
Forty sheep and 40 heifers were dosed with an intraruminal slow release capsule (IRSRC) constructed to deliver albendazole (ABZ) at a low daily dosage for three months. Blood samples were collected at standardised intervals for 110 days and analysed by high performance liquid chromatography for the quantification of the two main metabolites sulphoxide (SO.ABZ) and sulphone (SO2ABZ). The plasma profiles show sustained concentrations of the active metabolite SO.ABZ for 105 days in sheep (m = 0.06 +/- 0.032 micrograms ml-1) and 85 days in cattle (m = 0.10 +/- 0.019 micrograms ml-1). In both species, the proportions of the metabolites were inverted compared to that observed after a single dosage. The bioavailability of ABZ after the administration of the IRSRC compared with a drench was reduced in sheep but increased in cattle. The IRSRC exhibited a preventive and therapeutic effect for at least three months.
Delatour
P
P
National School of Veterinary Medicine, Lyons, France.
Benoit
E
E
Lechenet
J
J
Besse
S
S
D015766:Albendazole / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000818:Animals; D001682:Biological Availability; D002417:Cattle / Q000378:metabolism*; D003692:Delayed-Action Preparations; D005260:Female; D012417:Rumen / Q000378:metabolism; D012756:Sheep / Q000378:metabolism*; D013450:Sulfones / Q000097:blood; D013454:Sulfoxides / Q000097:blood
D003692:Delayed-Action Preparations; D013450:Sulfones; D013454:Sulfoxides; D015766:Albendazole